Post-traumatic stress disorder (PTSD) is characterized by symptoms such as repeated, intrusive upsetting memories of the trauma; avoidance of similar situations and things which might remind one of them; a feeling of detachment from others; hypervigilance, and overarousal. It is associated with problems at work and at home and it is estimated that between 1% and 14% of people might suffer from it over the course of their lifetime. A team of researchers from New York reviewed 57 studies into treatments for PTSD and acute stress disorder which can often lead to it. They found that there was the strongest evidence for trauma-focused cognitive-behavioural therapy (CBT) and eye-movement desensitization and reprocessing (EMDR). There was some evidence that stress innoculation training, hypnotherapy, interpersonal psychotherapy and psychodynamic psychotherapy were effective for PTSD and that trauma-focused CBT was effective for acute stress disorder. The study also found evidence that trauma-focused CBT was effective for assault- and road-traffic-accident-related PTSD.
Ponniah, Kathryn and Hollon, Steven D. - Empirically supported psychological treatments for adult acute stress disorder and posttraumatic stress disorder: a review Depression and Anxiety December 2009, 26(12), 1086-1109
-
Posts
1 comment:
CONTACT:
Paul Jaffe
MAADDSG@aol.com
www.maaddsg.org
845-278-3022
the Manhattan
Adult Attention Deficit Disorder
Support Group
presents:
CAN STRESS SHAPE THE BRAIN?
CAN SCIENCE MAKE IT RESILIENT?
After a rough time, most of us will bounce back. But some won't.
So, too, with mice. Traumatize them -- and some shake it off. While others slink into a corner, and stay there.
Why? We now know more than we did. And researchers -- using "gene vectors" -- have found ways to free the defeated mice from behavioral paralysis.
But could these tools be moved out of the lab? And used to help patients with treatment-resistant cases of depression or post-traumatic stress disorder? To make this happen, what hurdles would need to be jumped?
Leading our discussion will be Dr. Scott Russo, an assistant professor of neuroscience at NYC's Mount Sinai School of Medicine. Dr. Russo also heads that school's Laboratory of Neuroplasticity and Behavior.
He'll speak on Thursday, February 11 -- from 7pm to 9pm -- at St. Vincent's Hospital Manhattan.
This will be in the Cronin Auditorium -- at 170 West 12th Street, on the 10th floor -- which can be reached through the Smith Pavilion entrance between Sixth Avenue and Seventh Avenue.
Doors will open at 6:30.
-------------------
about MAADDSG
Since 1991, the Manhattan Adult Attention Deficit Disorder Support Group has offered walk-in, peer-run support sessions for adults with ADD and ADHD in the New York metro area. In addition, it sponsors workshops led by experts in ADD/ADHD and other aspects of mental health.
Post a Comment